ATRC
19.2.2024 19:39:33 CET | Business Wire | Press release
The UAE’s Advanced Technology Research Council (ATRC), mandated to shape an advanced R&D ecosystem in Abu Dhabi, signed a Memorandum of Understanding (MoU) with the Ministry Of Digital Technologies of the Republic of Uzbekistan, on the sidelines of the World Governments Summit (WGS) 2024. This synergy aims to leverage the technical expertise of ATRC and its subsidiaries for the seamless integration of Artificial Intelligence (AI) across Uzbekistan’s technological infrastructure and government services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240219748628/en/
His Excellency Shahab Issa Abu Shahab, Director General of ATRC and H.E. Sherzod Shermatov, Minister of Digital Technologies of Uzbekistan signing the Memorandum of Understanding on the sidelines of WGS 2024. (Photo: AETOSWire)
Under the terms of the agreement, Uzbekistan will explore and drive the adoption of Falcon LLMs and Falcon-powered solutions, as well as support the use of Falcon within its digital ecosystem across diverse use cases. Furthermore, Uzbekistan will encourage organizations and entities to join the recently announced ‘Falcon Foundation’ and contribute to the advancement of open-source Falcon models. The partnership marks a significant stride in exporting Falcon’s capability at a state level beyond the Middle East, laying the groundwork for global collaborative initiatives that will define the future of technological innovation.
Expressing optimism about the alliance, His Excellency Shahab Issa Abu Shahab, Director General of ATRC said: “The signing of this agreement underscores ATRC's steadfast dedication to forging global partnerships in the realm of AI. Collaborating closely with the government of Uzbekistan, we look forward to supporting the wider adoption of Falcon's pioneering solutions across diverse organizations within the country."
H.E. Sherzod Shermatov, Minister of Digital Technologies of Uzbekistan, said: “We are pleased to join forces with ATRC, in encouraging innovation as we integrate the state-of-the-art Falcon AI models into Uzbekistan’s technological infrastructure and government services. Our joint efforts are poised to fast-track innovation and help us overcome digital barriers to achieve our potential.”
Falcon LLM, a world-leading open-source AI model, is part of the Falcon series of powerful large language models developed by the Technology Innovation Institute (TII), ATRC’s applied research arm. ATRC and its commercialization arm VentureOne launched a pioneering AI company AI71 in November 2023 to deliver specialized AI models for clients – both companies and countries, while giving them the option of decentralized data ownership. Both TII and AI71 offer vital channels for the deployment of the Falcon series of LLMs.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240219748628/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Splio Enters a New Phase of Its Regional Development in Southern Europe19.5.2026 09:00:00 CEST | Press release
As consumers integrate AI into their everyday web usage, Splio is strengthening its presence in Barcelona to help companies across the region make CRM a central lever in the age of agentic commerce Splio is strengthening its presence in Barcelona, which is set to play the role of a second headquarters, to drive its development across Southern Europe.Splio is reinforcing governance, teams and resources deployed in the region.With its AI-first CRM, Splio aims to help companies from retail to travel strengthen the business contribution of CRM. A few months after launching its AI-first CRM, Splio is entering a new phase of its development in Southern Europe. Already established for more than 12 years in Spain, Portugal and Italy, the company has chosen to invest further in the region, convinced that it combines economic potential with rapidly evolving digital usage. Antoine Parizot, Splio’s co-CEO, is relocating to Barcelona, where the company’s historic office is based. At the same time,
KfW, Germany’s largest national promotional bank, future-proofs regulatory reporting, by migrating to Regnology Reporting Hub (RRH)19.5.2026 08:33:00 CEST | Press release
Longstanding client transitions to the next-generation RRH solution, delivered on Regnology’s Rcloud architecture Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced that KfW Bankengruppe (KfW) is advancing its long-term partnership with the company by electing to migrate to the next-generation Regulatory Reporting Hub (RRH). The solution will be delivered as a cloud-native service on Rcloud, Regnology’s high-performance cloud architecture layer. This strategic move to the modern RRH platform future-proofs the mission-critical reporting functions for one of the world's leading promotional banks. Headquartered in Frankfurt am Main, KfW is a public‑law institution dedicated to supporting sustainable economic, social and ecological development in Germany, across Europe and globally. Regnology’s foresight led to the 2023 launch of Rcloud, its state-of-the-art architecture layer built on Google Cloud, enabling next‑generation so
ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth19.5.2026 08:00:00 CEST | Press release
ATB Therapeutics (“ATB” or the “Company”), a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, today announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513198633/en/ ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth Mark Throsby has served as Executive Chairman and Chief Scientific Officer since 2024, during which time he supported the Company’s growth, including the successful closing of its Series A financing, the expansion of the scientific team, and the advancement of its therapeutic programs. In his new role, he will lead ATB’s strategy and senior leadership team as the Company prepares to enter clinical deve
TREASoURcE Shows How Circular Economy Solutions Can Move Beyond Pilots Across Sectors and Regions19.5.2026 07:00:00 CEST | Press release
Across Europe, many circular economy solutions struggle to move beyond isolated pilots and into real-world deployment at scale. New approaches are needed that combine technical feasibility, market relevance and citizen engagement, while remaining adaptable to local contexts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518914041/en/ TREASoURcE addressed circular economy challenges across energy, plastics and biobased side streams, combining technical solutions with stakeholder and citizen engagement. The EU-funded TREASoURcE project provides evidence that systemic, citizen-engaged circular economy solutions can be developed, tested and prepared for replication across regions. Using a common regional approach, the project combined real-life demonstrations, cross-value chain collaboration and early consideration of transferability to translate circular economy concepts into practical solutions in the fields of energy, mat
Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer19.5.2026 07:00:00 CEST | Press release
Experienced biotech finance leader with over 30 years’ experience in capital markets and strategyProven track record in fundraising, M&A and company transformationCompany is currently running two pivotal Phase 3 studies with nizubaglustat in GM1/ GM2 gangliosidoses and Niemann-Pick type C disease Azafaros, a private company building a portfolio to become a leader in Lysosomal Storage Disorders and focused on addressing neurological symptoms, today announced that Amy Sullivan has joined the company as Chief Financial Officer. Ms. Sullivan brings more than 30 years’ experience in the life sciences sector, with expertise in capital raising, corporate strategy and communications. She joins Azafaros from IO Biotech, where she served as Chief Financial Officer. “Amy is a highly accomplished financial leader with a strong track record of supporting growth-stage biotech companies,” said Stefano Portolano, Chief Executive Officer at Azafaros. “Her expertise in financing, strategic positioning a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom